ID: ALA3809978

Max Phase: Preclinical

Molecular Formula: C24H26N6O5

Molecular Weight: 478.51

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1cc(CNc2nc3c(N)ncnc3n2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)ccc1-c1ccccc1

Standard InChI:  InChI=1S/C24H26N6O5/c1-34-16-9-13(7-8-15(16)14-5-3-2-4-6-14)10-26-24-29-18-21(25)27-12-28-22(18)30(24)23-20(33)19(32)17(11-31)35-23/h2-9,12,17,19-20,23,31-33H,10-11H2,1H3,(H,26,29)(H2,25,27,28)/t17-,19-,20-,23-/m1/s1

Standard InChI Key:  HTHVSNVHGMBJSO-ZDXOVATRSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 478.51

Molecular Weight (Monoisotopic): 478.1965

AlogP: 1.31

#Rotatable Bonds: 7

Polar Surface Area: 160.80

Molecular Species: NEUTRAL

HBA: 11

HBD: 5

#RO5 Violations: 1

HBA (Lipinski): 11

HBD (Lipinski): 6

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 12.45

CX Basic pKa: 4.47

CX LogP: 1.28

CX LogD: 1.28

Aromatic Rings: 4

Heavy Atoms: 35

QED Weighted: 0.26

Np Likeness Score: 0.20

References

1. Tatani K, Hiratochi M, Kikuchi N, Kuramochi Y, Watanabe S, Yamauchi Y, Itoh F, Isaji M, Shuto S..  (2016)  Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: Potential Treatment for Hyperuricemia and Gout.,  59  (8): [PMID:27007871] [10.1021/acs.jmedchem.5b01884]

Source

Source(1):

• Scientific Literature